Feedback / Questions
intismeran autogene (mRNA-4157) - Merck (MSD), Moderna
Intismeran autogene: Regulatory filing for adjuvant melanoma through 2028
(Moderna)
-
Aug 4, 2025 -
Q2 2025 Results
Filing
•
Melanoma • Oncology
https://irp.cdn-website.com/89dd0539/files/uploaded/Moderna+2Q25+Earnings+Presentation+-+FINAL.pdf
Aug 4, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious